Chronic respiratory illnesses affect millions. Learn how PCPs can effectively manage asthma, COPD, and allergies through ...

According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of ...

More than 80 million people in Europe are affected, and many more are undiagnosed, with primary care practitioners ill-prepared to identify the conditions.

Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to a new study. The study ...

A 6-minute walk of less than 350 meters tripled the mortality risk, whereas chronic kidney disease (CKD) independently ...

chronic obstructive pulmonary disease (COPD), and ... How a New Gut Microbe Drives the Gut-Lung Axis Dec. 19, 2024 — A team has discovered a new communication pathway between the gut and lung.

New Partnership with Leonard Nimoy’s Daughter Aims to Raise COPD Awareness ...

as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD). Nucala stands out as the only approved biologic that has been ...

Sly Stone dies at the age of 82 and his death highlights the dangers of COPD a chronic lung disease linked to smoking and air ...

and lifestyle changes Chronic obstructive pulmonary disease, commonly referred to as COPD, is a group of progressive lung diseases. An estimated 32 million people in the United States have COPD.

Approval of Nucala marks the first biologic approved for chronic obstructive pulmonary disease patients with blood eosinophil counts as low as ≥150 cells/μL. The FDA has approved GSK’s Nucala ...

As many as 70 percent of COPD patients in the United States whose disease is not adequately controlled with inhaled triple therapy and who continue to experience exacerbations have a BEC ≥150 ...